Annual Current Liabilities
$14.65 M
+$4.16 M+39.73%
December 31, 2024
Summary
- As of March 12, 2025, MLYS annual total current liabilities is $14.65 million, with the most recent change of +$4.16 million (+39.73%) on December 31, 2024.
- During the last 3 years, MLYS annual current liabilities has risen by +$9.59 million (+189.79%).
- MLYS annual current liabilities is now at all-time high.
Performance
MLYS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$14.65 M
-$16.68 M-53.24%
December 31, 2024
Summary
- As of March 12, 2025, MLYS quarterly total current liabilities is $14.65 million, with the most recent change of -$16.68 million (-53.24%) on December 31, 2024.
- Over the past year, MLYS quarterly current liabilities has increased by +$4.16 million (+39.73%).
- MLYS quarterly current liabilities is now -53.24% below its all-time high of $31.32 million, reached on September 30, 2024.
Performance
MLYS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MLYS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.7% | +39.7% |
| 3 y3 years | +189.8% | +39.7% |
| 5 y5 years | +188.1% | +39.7% |
MLYS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +189.8% | -53.2% | +136.0% |
| 5 y | 5-year | at high | +189.8% | -53.2% | +189.8% |
| alltime | all time | at high | +189.8% | -53.2% | +189.8% |
Mineralys Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $14.65 M(+39.7%) | $14.65 M(-53.2%) |
| Sep 2024 | - | $31.32 M(+10.3%) |
| Jun 2024 | - | $28.40 M(+47.9%) |
| Mar 2024 | - | $19.20 M(+83.2%) |
| Dec 2023 | $10.48 M | $10.48 M(-22.6%) |
| Sep 2023 | - | $13.54 M(+118.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $6.21 M(-41.2%) |
| Mar 2023 | - | $10.56 M(+30.9%) |
| Dec 2022 | $8.07 M(+59.6%) | $8.07 M(+11.7%) |
| Sep 2022 | - | $7.22 M(+42.9%) |
| Dec 2021 | $5.05 M(-0.6%) | - |
| Dec 2021 | - | $5.05 M |
| Dec 2020 | $5.08 M | - |
FAQ
- What is Mineralys Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual current liabilities year-on-year change?
- What is Mineralys Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly current liabilities year-on-year change?
What is Mineralys Therapeutics annual total current liabilities?
The current annual current liabilities of MLYS is $14.65 M
What is the all time high annual current liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual total current liabilities is $14.65 M
What is Mineralys Therapeutics annual current liabilities year-on-year change?
Over the past year, MLYS annual total current liabilities has changed by +$4.16 M (+39.73%)
What is Mineralys Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of MLYS is $14.65 M
What is the all time high quarterly current liabilities for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly total current liabilities is $31.32 M
What is Mineralys Therapeutics quarterly current liabilities year-on-year change?
Over the past year, MLYS quarterly total current liabilities has changed by +$4.16 M (+39.73%)